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Abstract
Background: Eosinophilic inflammation is a hallmark of chronic rhinosinusitis with nasal polyps. To model this disease
process experimentally, nasal sensitization of mice with ovalbumin or aspergillus has been described. Here, we describe a
genetically mutant mouse that develops robust spontaneous nasal eosinophilic inflammation. These mice lack the enzyme
SHP-1 that down-regulates the IL-4Ra/stat6 signaling pathway. We compared nasal inflammation and inflammatory
mediators in SHP-1 deficient mice (mev) and an ovalbumin-induced nasal allergy model.
Methods: A novel technique of trans-pharyngeal nasal lavage was developed to obtain samples of inflammatory cells from
the nasal passages of allergic and mev mice. Total and differential cell counts were performed on cytospin preparations.
Expression of tissue mRNA for IL-4, IL-13, and mouse beta-defensin-1 (MBD-1) was determined by quantitative PCR. Eotaxin
in the lavage fluid was assessed by ELISA.
Results: Allergic and mev mice had increased total cells and eosinophils compared with controls. Expression of IL-4 was
similarly increased in both allergic and mev mice, but expression of IL-13 and eotaxin was significantly greater in the allergic
mice than mev mice. Eotaxin was significantly up-regulated in both allergic rhinitis and mev mice. In both models of
eosinophilic inflammation, down-regulation of the innate immune marker MBD-1 was observed.
Conclusions: The mev mice display spontaneous chronic nasal eosinophilic inflammation with potential utility for chronic
rhinosinusitis with nasal polyps research. The eosinophilic infiltrate is more robust in the mev mice than allergic mice, but
Th2 cytokine expression is not as pronounced. Decreased MBD-1 expression in both models supports the concept that Th2-
cytokines down-regulate sinonasal innate immunity in humans, and suggests a role for mouse models in investigating the
interaction between adaptive and innate immunity in the sinonasal mucosa.
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Introduction
A defining characteristic of chronic rhinosinusitis with nasal
polyps (CRSwNP) is the presence of an eosinophilic inflammatory
infiltrate and a Th2 cytokine predominance [1]. The initiating
cause of CRSwNP is unknown, and the pathologic processes that
underlie the persistent inflammation are poorly understood. In
order to study the cellular and molecular basis of CRSwNP, model
systems have been described in vitro and in animal species,
including rodents and sheep [2,3]. While mouse sinuses lack the
size and anatomic features of human sinuses, these model systems
have the significant advantage of powerful genetic tools available
to manipulate gene expression experimentally. In recent years,
allergen challenge models have been created that result in chronic
eosinophilic rhinosinusitis in mice [4]. However, no transgenic
mouse models have been utilized to explore genetically-driven
Th2-biased sinonasal inflammation.
The sinonasal mucosal immune system plays a critical role in
protecting the host from potential pathogens that enter the airway
during breathing. Sinonasal epithelial cells act as sentinels and
early responders, detecting pathogen-associated molecules via
pattern-recognition receptors and elaborating a variety of
antimicrobial effectors [5,6]. They interact bi-directionally with
intra-epithelial lymphocytes and other adaptive immune elements
in order to coordinate an antimicrobial defense. While the
underlying pathophysiology of CRSwNP remains under investi-
gation, gene expression analysis suggests that a number of proteins
involved in innate immunity, barrier function, and repair are
down-regulated in diseased sinus mucosa [7]. Whether this
alteration represents a cause or an effect of chronic inflammation
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directly suppress epithelial cell innate immune function in-vitro,
perhaps implying that the adaptive immune system mediates the
observed innate immune deficiency in CRSwNP [8,9]. Studies of
cellular and molecular mechanisms are difficult or impractical to
carry out in human patients, and in vitro models utilizing human
tissue have significant limitations. Thus, animal models of
sinonasal inflammation provide a critical opportunity to examine
the interplay between the innate and adaptive immune systems in
great depth.
Models of nasal allergic inflammation in the mouse support the
concept that Th2-mediated inflammation diminishes effective anti-
bacterial immunity in the airway. For example, Naclerio et al.
showed that mice with allergic rhinitis had a worse course of acute
sinusitis when inoculated with Streptococcus pneumonia [10]. Ongoing
allergic provocation resulted in an increased percentage of sinuses
with neutrophil clusters and more S. pneumoniae colonies at the time
of sacrifice. In addition, Beisswenger et al. used an allergic mouse
model to study pulmonary antimicrobial innate immune defense
[11]. Sensitized allergic mice inoculated with Pseudomonas aeruginosa
had a greater number of viable bacteria in the lung 24 hours after
infection when compared to non-sensitized animals. In prelimi-
nary studies, we have demonstrated reduced innate immune gene
expression in a nasally-sensitized ovalbumin allergy model. While
allergic rhinosinusitis mouse models do achieve a localized Th2-
skewed immune response, the degree and persistence of eosino-
philic inflammation does not closely approximate that observed in
CRSwNP.
Src homology 2 domain-containing protein tyrosine phospha-
tase (SHP-1) is a negative regulator of the IL-4Ra signaling
pathway. Once phosphorylated and activated, SHP-1 binds to and
dephosphorylates its target molecules to terminate signaling [12].
A genetically-altered mouse strain known as motheaten viable (mev)
has been found that is deficient in SHP-1. This mouse develops an
asthma-like phenotype in the lung with a very prominent
eosinophilic infiltrate [13,14]. While the lower airway has been
studied in detail, the phenotype of the upper airway of mev mice
has not been reported. In this paper, we characterized nasal
inflammation in this mutant mouse, and compare its features to
the commonly-utilized allergen sensitization model. It is hoped
that detailed study of eosinophilic sinonasal inflammation in mice
will permit insights into human CRSwNP that will direct future
investigation and novel therapeutic strategies.
Materials and Methods
Animals
Female BALB/c and mev (Ptpn
6mev) mice (6–8 weeks old) were
obtained from the Jackson Laboratory (Bar Harbor, Maine).
Heterozygous mice (Ptpn
6mev/+, C57BL/6 background) were
interbred to generate WT, heterozygous, and homozygous mice.
In this study, we used mev homozygous mice (n=12) as a
spontaneous eosinophilic rhinitis model and WT littermates
(n=11) as untreated controls. BALB/c mice were used for PBS
controls (n=13) and OVA-induced allergic rhinitis (n=11).
Animals were housed in a specific pathogen-free facility with
single ventilated cages and received OVA-free diet. All animal
experiments were approved by the Johns Hopkins Institutional
Animal Care and Use Committee.
Allergen sensitization and challenge
Ovalbumin (OVA, grade V; Sigma Chemical Co, St Louis, Mo)
was used for nasal sensitization of BALB/c mice. The mice were
positioned supine and maintained in an awake state without use of
sedatives. For the first two weeks, mice were sensitized five time
per week by local intranasal instillations of 100 mg of OVA in
20 ml of PBS without alum (Al(OH)3). After sensitization, from day
15 to 56, mice were challenged intranasally two times per week
(total 12 times) with the same OVA preparation (Figure 1).
Control groups were challenged with equivalent volumes of PBS.
Trans-pharyngeal nasal lavage and cytology
All samples were collected 48 hours after the last allergen
challenge. After mice were anesthetized, the left ventricle was
cannulated and systemic blood was cleared by perfusion with cold
PBS. To obtain nasal airway lavage (NAL) samples, a trans-
pharyngeal modification of the previously described trans-tracheal
technique [15] was developed. The upper airway, including
palatopharyngeal region, was isolated by scissor dissection, and the
mouse head was separated at the level of the larynx. A 24G IV
catheter was inserted through the pharyngeal opening into the
choana (Figure 2A). Two consecutive volumes of 350 ml of PBS
were instilled, and the fluid was collected from the nostrils. NAL
fluids were centrifuged, and supernatants were stored at 280uC
until assayed. The cell pellet was resuspended with 100 ml PBS and
the total number of cells was determined. Cytospin slides were
prepared and stained with Diff-Quik stain (Dade Behring-
Switzerland), followed by differential count of at least 200 cells
per slide. The yield of trans-pharyngeal NAL was directly
compared to trans-tracheal technique, demonstrating a signifi-
cantly increased volume of recovered fluid with the trans-
pharyngeal method (93.4%61.05 versus 74.6%61.78 with the
trans-tracheal method, P=0.0001, Figure 2B).
Harvesting of nasal mucosa and histology
To harvest nasal tissues for mRNA extraction, the skull was
bisected sagittally, and septal and turbinate mucosa were removed
and placed in 1 ml of RNAlater solution (Ambion, Inc). The tissue
was stored in 4uC until RNA extraction. For nasal histology,
mouse heads were fixed with paraformaldehyde and decalcified for
2 days before embedment in paraffin. Coronal paraffin sections
were cut on a microtome and stained with hematoxylin and eosin
(H&E). Images were acquired using the Zeiss Axio Imager.A2
microscope and measurements made using the Axiovision 4.8
software (Carl Zeiss Micro-imaging, Thornwood, NJ). The
number of infiltrated eosinophils was counted on respiratory
turbinate sections at five random high power fields (HPF, 406)
and calculated mean values for comparison. To demonstrate
mucosal remodeling, epithelial thickness was measured at the same
respiratory turbinate locations, from the basement membrane to
the nasal lumen.
Figure 1. Experimental design used to study the effect of nasal
exposure to ovalbumin in mice. BALB/c mice (11–13 per group)
were sensitized by intranasal administration of 100 mg of ovalbumin in
20 ml PBS in the absence of adjuvants 5 times a week for 2 weeks. After
that, mice were challenged by intranasal administration of same dose of
ovalbumin two times a week for 6 weeks. As a control, mice were
treated with PBS with the same protocol. Two days after the last
challenge, mice were sacrificed for obtaining the NAL fluids and tissue
samples.
doi:10.1371/journal.pone.0035114.g001
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Total RNA was isolated with the RNeasy Mini kit (Qiagen,
Valencia, CA) using the manufacturer’s protocol. RNA was
quantified spectrophotometrically and absorbance ratios at 260/
280 nm were .1.80 for all samples studied. Five hundred
nanograms of total RNA was reverse transcribed in a 20 ml
volume with random hexamer primers (Invitrogen, Carlsbad, CA),
20 U of RNase inhibitor (Applied Biosystems, Foster City, CA),
and the Omniscript RT kit (Qiagen) under conditions provided by
the manufacturer.
Real-time polymerase chain reaction
Real-time PCR was performed using the Applied Biosystems
StepOnePlus machine (Foster City, CA) under standard cycling
parameters. The Taqman gene expression system (Applied
Biosystems) was used to measure mRNA levels of IL-4, IL-13,
and mouse b-defensin-1 (MBD-1). The reaction mix consisted of
0.5 mg total RNA for target genes or 0.05 ng total RNA for
GAPDH, 10 ml of TaqMan Fast Universal PCR Master Mix, 1.5–
5 mol/L probe target genes or 1.0 mol/L probe GAPDH, in a
total volume of 20 ml. Each PCR run was accompanied by
housekeeping gene GAPDH as an internal control. Amplicon
expression in each sample was normalized to its GAPDH RNA
content and the level of expression of target mRNA was
determined as the delta Ct, the difference in threshold cycles for
each target and housekeeping gene. Relative gene expression was
calculated by the 2
2DCt.
Measurement of eotaxin in the NAL fluids
Standard antibody-based ELISAs were used to measure
concentrations of eotaxin (polyclonal mouse anti-eotaxin, R&D
systems) in the NAL fluid samples. The limit of detection for the
eotaxin ELISA kit was 3.0 pg/ml.
Statistical analysis
All values are shown as mean 6 standard deviation of the mean.
Total cell and differential cells count in three groups were
compared with two-way ANOVA test. The expression of
inflammatory mediator mRNA between genetically matched
groups was compared with non-parametric test (Mann-Whitney
test). Statistical significance was considered to be P,.05. Results
were analyzed with the use of the statistical software Prism 4
(GraphPad, Inc).
Results
Increased total cells and eosinophils in NAL fluids in
allergic rhinitis and mev mice
Because the OVA-induced allergic rhinitis model was induced
in BALB/c background mice, comparisons with PBS controls were
made in BALB/c mice. The mev mice were generated in C57BL/6
background and were therefore compared with untreated C57BL/
6 mice. The total cell numbers in the NAL was significantly
increased in both allergic rhinitis (Figure 3A. 1.45610
4 cells,
P,0.0001) and mev mice (Figure 3B. 2.28610
4 cells, P,0.0001)
compared with their respective controls. Differential cell counts of
the NAL fluids were performed on cytospins using morphology
criteria (Figure 3C). The number of eosinophils in the NAL was
significantly increased in both allergic rhinitis (5.94610
3 cells,
P,0.05) and mev mice (8.19610
3 cells, P,0.0001) to similar levels.
The percentage of macrophages was also significantly increased in
both allergic rhinitis (P,0.001) and mev mice (P,0.0001)
compared to controls.
Tissue eosinophilia is induced by OVA challenge and
SHP-1 enzyme deficiency
We compared hematoxylin and eosin stains of the nasal cavity
from WT, allergic rhinitis mouse model and mev mice (Figure 4A).
In untreated C57BL/6 and PBS treated BALB/c mice, there was
no evidence of nasal inflammation and epithelial change.
However, in allergic rhinitis and mev mice, there was severe tissue
inflammation with eosinophilia. The number of infiltrating
eosinophils per HPF was significantly increased in allergic rhinitis
(P,0.0001) and mev mice (P,0.0001) compared with controls
(Figure 4B). Compared with the epithelium of controls and mev
mice, the turbinate epithelium of OVA-induced allergic rhinitis
was significantly thickened (P,0.0001, Figure 4C). However,
there was no definite evidence of epithelial remodeling in mev mice
compared with controls.
Expression of Th2 cytokines in allergic rhinitis and mev
mice
mRNA expression of the Th2 cytokines IL-4 and IL-13 was
assessed in the nasal mucosal samples and compared between the
genetically matched groups (Figure 5). IL-4 significantly increased
in both allergic rhinitis (8.34 fold, P=0.0424) and mev mice (11.16
fold, P=0.024) compared with respective controls. IL-13 was
Figure 2. The method of NAL technique used in this study. (A) Photograph of the trans-pharyngeal approach to obtain nasal lavage samples
from mouse models. (B) Comparison of yields in the recovered fluid volume after the NAL between trans-tracheal and trans-pharyngeal approaches
(***p,0.001).
doi:10.1371/journal.pone.0035114.g002
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but not in mev mice.
Increased eotaxin in the NAL fluids of allergic rhinitis and
mev mice
The levels of eotaxin in the NAL fluids were measured by
ELISA (Figure 6). Eotaxin was significantly up-regulated in both
allergic rhinitis (161.4 pg/ml640.16, P=0.0036) and mev mice
(11.9 pg/ml69.53, P=0.04) when compared with controls.
Eotaxin in the NAL fluids showed same basal level of expression
in controls of BALB/c and C57BL/6 mice.
Decreased expression of MBD-1 in allergic rhinitis and
mev mice
The mRNA expression of MBD-1 significantly decreased in
both allergic rhinitis (3.44 fold, P=0.0242) and mev mice (1.79
Figure 3. Cytology in the NAL fluids of allergic rhinitis and mev mice. (A and B) Total and differential cell counts in the NAL fluids collected
from controls, allergic rhinitis (OVA) and mev mice (*p,0.05, **p,0.01, and ***p,0.001). (C) Representative photos showing macrophages and
eosinophils (Diff-Quick stain, 406).
doi:10.1371/journal.pone.0035114.g003
Figure 4. Histology of allergic rhinitis and mev mice. (A) Hematoxylin and eosin stains of the nasal cavity from controls, allergic rhinitis (OVA)
and mev mice. (B) In allergic and mev mice, there is clearly increased nasal inflammation with eosinophilia, as compared to controls. (C) Epithelial
thickness significantly increased in allergic mice compared with controls and mev mice (*p,0.05, **p,0.01, and ***p,0.001).
doi:10.1371/journal.pone.0035114.g004
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Discussion
Animal models provide an important experimental platform for
studying pathophysiologic mechanisms in CRS. Mice are a
particularly attractive system for model development because they
are genetically homogeneous and there is a large body of
information present in the literature about the cellular, biochem-
ical, molecular biological aspects of inflammation in this species.
Furthermore, mice are the only practical species in which
transgenic animals can be generated, and specific targeted
mutations in existing mouse strains are available. One of the
central characteristics of human CRSwNP is the presence of
profound Th2-skewed sinonasal eosinophilic inflammation [1].
While certain aspects of this inflammatory state may be mimicked
in a mouse that is sensitized and intranasally challenged with
antigen for an extended period of time, the development of
genetically-modified mice with spontaneous eosinophilic inflam-
mation may afford new insights that are complementary and
extend our understanding.
As mouse models are generated and optimized to the study of
CRS, it is critical to establish outcome measures that quantify the
inflammatory state and response to intervention. The novel nasal
lavage technique described in this paper is simple to perform,
inexpensive, and shows cell count results that mirror histological
features. Most importantly, our NAL techniques showed an
excellent yield having increased returned fluid volume after NAL
and remarkable consistency among different samples when
compared with the more conventional trans-tracheal NAL method
(Figure 2). This difference is likely due to leakage of trans-tracheal
lavage fluid through the oral cavity. The analysis of cell counts and
mediator levels using this novel trans-pharyngeal NAL provides a
broadly applicable tool to characterize the severity and type of
inflammatory responses in mouse models of sinonasal disease.
There is an extensive literature regarding allergen-induced
lower and upper airway inflammation models in mice. In most
cases, the inflammation is generated by systemic sensitization
through the intraperitoneal or subcutaneous route with subsequent
local challenge with nebulized or intranasal allergen [16,17]. In
the present study, we have successfully created a similar model
using 8 weeks of intranasal OVA instillation without systemic
injection or use of any adjuvant such as alum. We observe a robust
eosinophilic tissue infiltrate, increased mRNA expression of Th2
cytokines IL-4 and IL-13 and protein expression of eotaxin in
OVA mouse model. It is important to recognize that although
mouse rhinosinusitis models have been previously described using
fungal extracts for sensitization, the resulting eosinophilic
inflammatory response does not appear to be dependent on the
antigen [18]. In other words, there is no evidence that sinonasal
inflammation in the mouse triggered by aspergillus better models
features of human CRS (fungal-related or otherwise) than does
ovalbumin or another antigen.
Strain-specific phenotypic differences between BALB/c and
C57BL/6 mice are well known in asthma and allergic rhinitis
models, with differences described in pro-inflammatory cytokines
and inflammatory cells [19,20]. BALB/c mice are Th2 prone,
while C57BL/6 mice favor Th1 inflammation. Preliminary
attempts to generate OVA-induced allergic rhinitis in the
C57BL/6 mice did not result in reliably robust responses (data
not shown). Therefore, we studied OVA-induced allergic rhinitis
and mev mice with the use of strain-matched controls.
Figure 5. Relative mRNA expression of Th2 cytokines (IL-4 and
IL-13) in controls, allergic rhinitis (OVA), and mev mice
(*p,0.05 and ***p,0.001). IL-4 is significantly up-regulated in both
allergic rhinitis and mev mice compared with controls. However, IL-13
significantly increased only in OVA model.
doi:10.1371/journal.pone.0035114.g005
Figure 6. Eotaxin expression in the NAL fluids of controls,
allergic rhinitis (OVA) and mev mice. Eotaxin significantly increased
in both OVA model and mev mice compared to controls while it was
significantly higher in OVA model than mev mice (*p,0.05 and
**p,0.01).
doi:10.1371/journal.pone.0035114.g006
Figure 7. Relative mRNA expression of MBD-1 in controls,
allergic rhinitis (OVA), and mev mice (*p,0.05 and **p,0.01).
Expression of MBD-1 significantly decreased in both OVA model and
mev mice.
doi:10.1371/journal.pone.0035114.g007
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IL-4 receptor over-activity with spontaneous inflammation
developing in multiple organs, including, most prominently, the
lung [19,20,21]. The pulmonary inflammation is Th2-skewed,
evidenced by increased eosinophils in bronchoalveolar lavage,
mucous metaplasia, epithelial hypertrophy, and subepithelial and
parenchymal fibrosis in the lung tissue [13,14]. At the molecular
level, Th2 cytokines and chemokines, as well as phosphorylated
STAT6, were significantly upregulated in the lungs of mev mice as
compared with WT mice. Using a targeted gene deletion
approach, the pulmonary inflammation in mev mice showed IL-
13, IL-4Ra, and STAT6-dependence in the lung [13]. In the
present study, we demonstrate that deficiency of SHP-1 also results
in a sinonasal phenotype, characterized by eosinophilic rhinosi-
nusitis comparable to the OVA-induced allergic rhinitis mouse
model. In future studies, the downstream signaling pathways
modulated by SHP-1, including IL-4Ra/STAT6 and phosphati-
dylinositol 3-kinase (PI3K) will be investigated in the mev mouse, to
elucidate the interplay between Th2 cytokine signaling and innate
immunity, barrier function, and repair.
While the innate and adaptive immunity represent two distinct
arms of host defense, studies with human tissue suggest that a
complex interaction exists between the two that may be
dysregulated in CRS [7,9]. Genetically mutant mouse models
such as mev mice allow specific features of CRSwNP to be
mimicked in an in vivo situation, in order to begin to dissect some of
these critical relationships experimentally in a way that is not
possible in human subjects or in cell or tissue explants culture
systems. The comparison between the mev and the allergic
rhinosinusitis mouse models demonstrates similarity in the overall
eosinophilic inflammatory picture, but significant differences in the
expression of the Th2-associated mediators IL-13 and eotaxin. In
the lungs of mev mice there is a robust eosinophilia in
bronchoalveolar lavage and the parenchyma with strong evidence
of Th2-skewed inflammation [13,14]. Although the nasal cavity
also displays eosinophilic inflammation in the NAL fluids and
mucosa, evidence for a Th2 inflammatory response is not as
pronounced. Further studies are needed to determine the
molecular mechanism underlying the spontaneous eosinophilic
inflammation in the sinonasal tract. Interestingly, in comparison to
the distinct increase in epithelial thickness seen in the OVA allergy
model, mev mice maintain a relatively normal appearance of the
nasal epithelium, despite the intense sub-epithelial eosinophilic
infiltrate (Figure 4). This suggests that the response of the
epithelium to Th2 inflammation may be shaped by other
endogenous and exogenous signals that contribute to mucosal
homeostasis.
In both models, expression of the innate antimicrobial MBD-1
is reduced, which is consistent with mRNA findings in human
CRSwNP tissue and sinonasal epithelial cells in vitro [22]. MBD-
1, a homolog of hBD-1, has antibacterial effects on gram-positive
and -negative bacteria and has been detected in bronchial
epithelial cells [23]. To our knowledge, the present study is the
first report on MBD-1 expression in either allergic rhinosinusitis
mouse models or mev mice. Further exploration in these mouse
models is warranted to investigate the interaction between Th2
cytokines and epithelial cell innate immune function. The
differential expression of inflammatory mediators between models
may allow the roles of individual cytokines to be dissected.
Because current medical and surgical interventions fail to
control CRSwNP effectively in the long-term, the condition can be
frustrating for patients and otolaryngologists alike [24]. At this
time, a significant obstacle to developing new therapeutic
strategies for CRSwNP is the absence of animal models that
allow study of the disease at the cellular and molecular level.
CRSwNP is a complex multifactorial condition, and it is unlikely
that a single animal model can reproduce all of the functional and
morphological features of the human disease state. However,
transgenic mouse strains can be created to mimic specific features
of the disorder, and by utilizing the wide array of specific reagents
available to dissect subcellular pathways of immunity and
inflammation, a much greater appreciation of critical underlying
mechanisms can be achieved. Thus, while larger animal species
have proven useful to model sinus infection and endoscopic
surgery, rigorous scientific investigation of inflammatory pathways
is better suited to mouse models. The mev mouse and other
transgenic and knockout strains either currently available or in
development have great potential to tremendously advance the
field of sinonasal mucosal immunology, with direct implications for
understanding chronic inflammation in CRSwNP.
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